SS Innovations International, Inc. is a medical robotics company, which develops a fully autonomous medical robotic system using proprietary software. The company is headquartered in Fort Lauderdale, Florida and currently employs 378 full-time employees. The company went IPO on 2018-07-09. The Company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. The SSi Mantra Surgical Robotic System is designed to enable surgeons to perform a wide range of surgical procedures including cardiovascular, thoracic, head and neck, gynecological, urological, cancer and general surgeries. The SSi Mantra 3 is comprised of components, such as Surgeon Console, Patient-Side Robotic Arm Carts, and Vision Cart. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset.
최신 재무제표(Form-10K)에 따르면, SS Innovations International Inc의 총 자산은 $31이며, 순손실입니다.
SSII의 주요 재무 비율은 무엇인가요?
SS Innovations International Inc의 유동비율은 2.81이고, 순이익률은 -400, 주당 매출은 $0.03입니다.
SS Innovations International Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
SS Innovations International Inc 주요 수익원은 System이며, 최신 수익 발표에서 수익은 5,692,721입니다. 지역별로는 India이 SS Innovations International Inc의 주요 시장이며, 수익은 5,879,710입니다.
SS Innovations International Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 SS Innovations International Inc의 순손실은 $-20입니다.
SS Innovations International Inc에 부채가 있나요?
예, SS Innovations International Inc의 부채는 11입니다.
SS Innovations International Inc의 발행 주식은 몇 주인가요?
SS Innovations International Inc의 총 발행 주식은 170.72주입니다.